Cargando…
High prevalence of COPD in atherosclerosis patients
Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the di...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655122/ https://www.ncbi.nlm.nih.gov/pubmed/29089753 http://dx.doi.org/10.2147/COPD.S141988 |
_version_ | 1783273470020288512 |
---|---|
author | Tuleta, Izabela Farrag, Tarik Busse, Laura Pizarro, Carmen Schaefer, Christian Pingel, Simon Nickenig, Georg Skowasch, Dirk Schahab, Nadjib |
author_facet | Tuleta, Izabela Farrag, Tarik Busse, Laura Pizarro, Carmen Schaefer, Christian Pingel, Simon Nickenig, Georg Skowasch, Dirk Schahab, Nadjib |
author_sort | Tuleta, Izabela |
collection | PubMed |
description | Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the diagnosis of cerebral and/or peripheral artery disease by means of duplex sonography, 166 consecutive patients underwent body plethysmography with capillary blood gas analysis. Thereafter, blood tests with determination of different parameters such as lipid profile, inflammatory and coagulation markers were conducted in remaining 136 patients who fulfilled inclusion criteria of the study. Thirty-six out of 136 patients suffered from COPD, mostly in early stages of the disease. Residual volume indicating emphysema was increased (162.9%±55.9% vs 124.5%±37.0%, p<0.05) and diffusion capacity was decreased (55.1%±19.5% vs 75.3%±18.6%, p<0.05) in COPD patients vs non-COPD group. In capillary blood gas analysis, COPD patients had lower partial pressure of oxygen (70.9±11.5 vs 75.2±11.0 mmHg, p<0.05) and higher partial pressure of carbon dioxide (36.8±7.5 vs 34.4±4.4 mmHg, p<0.05) compared with non-COPD individuals. Presence of COPD was associated with predominance of diabetes mellitus, interleukin-8-related systemic neutrophilic inflammation and anemia. In conclusion, COPD is highly prevalent in patients with atherosclerotic artery disease. |
format | Online Article Text |
id | pubmed-5655122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56551222017-10-31 High prevalence of COPD in atherosclerosis patients Tuleta, Izabela Farrag, Tarik Busse, Laura Pizarro, Carmen Schaefer, Christian Pingel, Simon Nickenig, Georg Skowasch, Dirk Schahab, Nadjib Int J Chron Obstruct Pulmon Dis Original Research Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other. The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD. Following the diagnosis of cerebral and/or peripheral artery disease by means of duplex sonography, 166 consecutive patients underwent body plethysmography with capillary blood gas analysis. Thereafter, blood tests with determination of different parameters such as lipid profile, inflammatory and coagulation markers were conducted in remaining 136 patients who fulfilled inclusion criteria of the study. Thirty-six out of 136 patients suffered from COPD, mostly in early stages of the disease. Residual volume indicating emphysema was increased (162.9%±55.9% vs 124.5%±37.0%, p<0.05) and diffusion capacity was decreased (55.1%±19.5% vs 75.3%±18.6%, p<0.05) in COPD patients vs non-COPD group. In capillary blood gas analysis, COPD patients had lower partial pressure of oxygen (70.9±11.5 vs 75.2±11.0 mmHg, p<0.05) and higher partial pressure of carbon dioxide (36.8±7.5 vs 34.4±4.4 mmHg, p<0.05) compared with non-COPD individuals. Presence of COPD was associated with predominance of diabetes mellitus, interleukin-8-related systemic neutrophilic inflammation and anemia. In conclusion, COPD is highly prevalent in patients with atherosclerotic artery disease. Dove Medical Press 2017-10-19 /pmc/articles/PMC5655122/ /pubmed/29089753 http://dx.doi.org/10.2147/COPD.S141988 Text en © 2017 Tuleta et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Tuleta, Izabela Farrag, Tarik Busse, Laura Pizarro, Carmen Schaefer, Christian Pingel, Simon Nickenig, Georg Skowasch, Dirk Schahab, Nadjib High prevalence of COPD in atherosclerosis patients |
title | High prevalence of COPD in atherosclerosis patients |
title_full | High prevalence of COPD in atherosclerosis patients |
title_fullStr | High prevalence of COPD in atherosclerosis patients |
title_full_unstemmed | High prevalence of COPD in atherosclerosis patients |
title_short | High prevalence of COPD in atherosclerosis patients |
title_sort | high prevalence of copd in atherosclerosis patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655122/ https://www.ncbi.nlm.nih.gov/pubmed/29089753 http://dx.doi.org/10.2147/COPD.S141988 |
work_keys_str_mv | AT tuletaizabela highprevalenceofcopdinatherosclerosispatients AT farragtarik highprevalenceofcopdinatherosclerosispatients AT busselaura highprevalenceofcopdinatherosclerosispatients AT pizarrocarmen highprevalenceofcopdinatherosclerosispatients AT schaeferchristian highprevalenceofcopdinatherosclerosispatients AT pingelsimon highprevalenceofcopdinatherosclerosispatients AT nickeniggeorg highprevalenceofcopdinatherosclerosispatients AT skowaschdirk highprevalenceofcopdinatherosclerosispatients AT schahabnadjib highprevalenceofcopdinatherosclerosispatients |